Literature DB >> 10027323

Peritoneal cytology in the surgical evaluation of gastric carcinoma.

N Hayes1, J Wayman, V Wadehra, D J Scott, S A Raimes, S M Griffin.   

Abstract

Many patients undergoing surgery for gastric carcinoma will develop peritoneal metastases. A method to identify those patients at risk of peritoneal recurrence would help in the selection of patients for adjuvant therapy. Peritoneal cytology has received little attention in the West, but may prove a useful additional means of evaluating patients with gastric cancer. The aims of this study were to evaluate sampling techniques for peritoneal cytology in patients with gastric cancer, to assess the prognostic significance of free peritoneal malignant cells and to discover the effect of the operative procedure on dissemination of malignant cells. The study is based on 85 consecutive patients undergoing surgical treatment of gastric cancer and followed up for 2 years or until death. Peritoneal cytology samples were collected at laparoscopy, and at operation prior to resection by intraperitoneal lavage and serosal brushings. After resection, samples were taken by peritoneal lavage, imprint cytology of the resected specimen and post-operatively by peritoneal irrigation via a percutaneous catheter. Malignant cells were diagnosed by two independent microscopists. Preoperative peritoneal lavage yielded malignant cells in 16 out of 85 cases (19%). The yield of free malignant cells was increased by using serosal brushings (by four cases) and imprint cytology (by two cases); all of the cases had evidence of serosal penetration. One serosa-negative case exhibited positive cytology in the post-resection peritoneal specimen in which the preresection cytology specimen was negative. Survival was worse in the cytology-positive group (chi2 = 25.1; P< 0.0001). Among serosa-positive patients, survival was significantly reduced if cytology was positive, if cases yielded by brushings and imprint cytology were included (log-rank test = 8.44; 1 df, P = 0.004). In conclusion, free peritoneal malignant cells can be identified in patients with gastric cancer who have a poor prognosis; the yield can be increased with brushings and imprint cytology in addition to conventional peritoneal lavage. Evaluation of peritoneal cytology by these methods may have a role in the selection of patients with the poorest prognosis who may benefit most from adjuvant therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10027323      PMCID: PMC2362407          DOI: 10.1038/sj.bjc.6690081

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer.

Authors:  A Hagiwara; T Takahashi; O Kojima; K Sawai; T Yamaguchi; T Yamane; H Taniguchi; K Kitamura; A Noguchi; K Seiki
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

2.  The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.

Authors:  G N Soosay; M Griffiths; L Papadaki; L Happerfield; L Bobrow
Journal:  J Pathol       Date:  1991-04       Impact factor: 7.996

3.  Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer.

Authors:  J J Bonenkamp; I Songun; J Hermans; C J van de Velde
Journal:  Br J Surg       Date:  1996-05       Impact factor: 6.939

4.  Prognostic and therapeutic values of peritoneal cytology in gastric cancer.

Authors:  T Nakajima; S Harashima; M Hirata; T Kajitani
Journal:  Acta Cytol       Date:  1978 Jul-Aug       Impact factor: 2.319

5.  Intraperitoneal free cancer cells and their viability in gastric cancer.

Authors:  Y Iitsuka; S Kaneshima; O Tanida; T Takeuchi; S Koga
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

6.  Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer.

Authors:  T Boku; Y Nakane; T Minoura; H Takada; M Yamamura; K Hioki; M Yamamoto
Journal:  Br J Surg       Date:  1990-04       Impact factor: 6.939

7.  Gastric cancer: a curable disease in Britain.

Authors:  H M Sue-Ling; D Johnston; I G Martin; M F Dixon; M R Lansdown; M J McMahon; A T Axon
Journal:  BMJ       Date:  1993-09-04

8.  Gastric cancer: a 25-year review.

Authors:  W H Allum; D J Powell; C C McConkey; J W Fielding
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

9.  Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma.

Authors:  N Kaibara; Y Iitsuka; A Kimura; Y Kobayashi; Y Hirooka; H Nishidoi; S Koga
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860

10.  A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group.

Authors:  W H Allum; M T Hallissey; L C Ward; M S Hockey
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  29 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

2.  Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients.

Authors:  Y T Lee; E K W Ng; L C T Hung; S C S Chung; J Y L Ching; W Y Chan; W C Chu; J J Sung
Journal:  Gut       Date:  2005-06-13       Impact factor: 23.059

3.  When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?

Authors:  Isao Miyashiro; Ko Takachi; Yuichiro Doki; Osamu Ishikawa; Hiroaki Ohigashi; Kohei Murata; Yo Sasaki; Shingi Imaoka; Akihiko Nakaizumi; Akemi Takenaka; Hiroshi Furukawa; Masahiro Hiratsuka
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

4.  Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.

Authors:  Esther W L Chuwa; Lay-Wai Khin; Weng-Hoong Chan; Hock-Soo Ong; Wai-Keong Wong
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

5.  Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.

Authors:  Ji-Kun Li; Miao Zheng; Chuan-Wen Miao; Jian-Hai Zhang; Guang-Han Ding; Wen-Shen Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

6.  Significance of lavage cytology in advanced gastric cancer patients.

Authors:  Takeo Fukagawa; Hitoshi Katai; Makoto Saka; Shinji Morita; Yuko Sasajima; Hirokazu Taniguchi; Takeshi Sano; Mitsuru Sasako
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

7.  Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2012-02-28       Impact factor: 3.402

8.  Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen.

Authors:  Yasuhiro Kodera; Hayao Nakanishi; Seiji Ito; Yoshitaka Yamamura; Michitaka Fujiwara; Masahiko Koike; Kenji Hibi; Katsuki Ito; Masae Tatematsu; Akimasa Nakao
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

9.  The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.

Authors:  Minkyu Jung; Hei-Cheul Jeung; Sung Sook Lee; Jun Yong Park; Soojung Hong; Soo Hyeon Lee; Sung Hoon Noh; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-23       Impact factor: 4.553

10.  Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice.

Authors:  T Matsuoka; J E Adair; F B Lih; L C Hsi; M Rubino; T E Eling; K B Tomer; M Yashiro; K Hirakawa; K Olden; J D Roberts
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.